Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Glaucoma: ocular Alzheimer's disease?

Stuart J McKinnon1

  • 1Department of Ophthalmology, University of Texas Health Science Center at San Antonio7703 Floyd Curl Drive, MC 6230, San Antonio, Texas 78229-3900, USA. mckinnon@uthscsa.edu

Frontiers in Bioscience : a Journal and Virtual Library
|September 6, 2003
PubMed
Summary

Glaucoma involves programmed cell death (apoptosis) of retinal ganglion cells (RGCs) via caspase activation. This process generates amyloid-beta, similar to Alzheimer's disease, suggesting shared therapeutic targets for neurodegeneration.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disease progression in iridocorneal angle tissues of BMP2-induced ocular hypertensive mice with optical coherence tomography.

Molecular vision·2015
Same author

Retinal nerve fiber layer reflectance for early glaucoma diagnosis.

Journal of glaucoma·2013
Same author

Dorsomedial/Perifornical hypothalamic stimulation increases intraocular pressure, intracranial pressure, and the translaminar pressure gradient.

Investigative ophthalmology & visual science·2012
Same author

The cell and molecular biology of glaucoma: common neurodegenerative pathways and relevance to glaucoma.

Investigative ophthalmology & visual science·2012
Same author

Distribution of amyloid precursor protein and amyloid-beta in ocular hypertensive C57BL/6 mouse eyes.

Current eye research·2010
Same author

Surgical management of hypotony owing to overfiltration in eyes receiving glaucoma drainage devices.

Journal of glaucoma·2009

Area of Science:

  • Ophthalmology
  • Neuroscience
  • Cell Biology

Background:

  • Glaucoma is a leading cause of age-related vision loss due to optic nerve neurodegeneration.
  • Retinal ganglion cells (RGCs) undergo apoptosis, a process involving caspase activation.
  • Caspase activation is implicated in neurodegenerative diseases like Alzheimer's disease (AD).

Purpose of the Study:

  • To investigate the role of caspases and amyloid precursor protein (APP) cleavage in RGC death in glaucoma.
  • To propose a novel hypothesis for RGC death in glaucoma involving amyloid-beta neurotoxicity.
  • To explore potential shared molecular mechanisms and therapeutic strategies between glaucoma and AD.

Main Methods:

  • Utilized rat glaucoma models to study RGC apoptosis.

Related Experiment Videos

  • Assessed the activation of caspase-3 and caspase-8 in RGCs.
  • Analyzed the cleavage of APP by caspases and the production of amyloid-beta fragments.

    • Main Results:

    • Caspase-3 activation was observed in RGCs, leading to APP cleavage and amyloid-beta production.
    • Caspase-8 was also found to be activated in RGCs.
    • These findings suggest chronic amyloid-beta neurotoxicity contributes to RGC death in glaucoma.

    Conclusions:

    • RGC death in glaucoma may result from chronic caspase activation, amyloid-beta cytotoxicity, and excitotoxicity.
    • The molecular pathways in glaucoma may mimic those in Alzheimer's disease.
    • Therapeutic strategies targeting AD could potentially benefit glaucoma patients, and vice versa.